ANAVEX LIFE SCIENCES CORP (AVXL) Stock Cash Flow
NASDAQ:AVXL - Nasdaq - US0327973006 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -46.49M | -43.00M | -47.51M | -47.98M | -37.91M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 1.67M | 2.75M | 2.51M | 5.36M | -710.00K | |||
| Taxes Paid | 296.00K | 300.00K | 140.00K | 330.00K | N/A | |||
| Other non cash items | 9.21M | 9.44M | 17.22M | 18.38M | 8.23M | |||
| OPERATING CASH FLOW | -35.61M | -30.81M | -27.79M | -24.24M | -30.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 12.62M | 11.97M | 29.65M | 21.99M | 158.79M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -710.00K | -5.55M | |||
| FINANCING CASH FLOW | 12.62M | 11.97M | 29.65M | 21.29M | 153.24M | |||
| Exchange Rate Effect | N/A | N/A | -40.00K | N/A | N/A | |||
| CHANGE IN CASH | -22.99M | -18.84M | 1.87M | -2.95M | 122.86M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.61M | -30.81M | -27.79M | -24.24M | -30.38M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -35.61M | -30.81M | -27.79M | -24.24M | -30.38M | |||
All data in USD